Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124600892 | 12460089 | 2 | F | 20131025 | 20160627 | 20160613 | 20160706 | PER | US-PFIZER INC-2016283975 | PFIZER | 44.00 | YR | M | Y | 0.00000 | 20160706 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124600892 | 12460089 | 1 | PS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | UNK | 20699 | PROLONGED-RELEASE CAPSULE | |||||||||
124600892 | 12460089 | 2 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 20699 | PROLONGED-RELEASE CAPSULE | |||||||||||
124600892 | 12460089 | 3 | C | ATIVAN | LORAZEPAM | 1 | UNK | 0 | |||||||||||
124600892 | 12460089 | 4 | C | LYRICA | PREGABALIN | 1 | UNK | 0 | |||||||||||
124600892 | 12460089 | 5 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124600892 | 12460089 | 1 | Depression |
124600892 | 12460089 | 2 | Anxiety |
124600892 | 12460089 | 3 | Anxiety |
124600892 | 12460089 | 4 | Fibromyalgia |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124600892 | 12460089 | Drug hypersensitivity | |
124600892 | 12460089 | Dyspnoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |